Open access publisher BioMed Central, UK, has announced that another three of its journals have been accepted and are well on their way to receive their first Impact Factors in June 2011.
The journals are: BMC Ophthalmology, Cell Division and Epigenetics & Chromatin. These journals have recently been accepted for citation tracking by Thomson Reuters, which takes the total of tracked BioMed Central journals to 102.
BMC Ophthalmology publishes original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of eye disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The journal is indexed/tracked/covered by PubMed, MEDLINE, CAS, EMBASE, Scopus and Google Scholar.
Cell Division is an Open Access, peer-reviewed online journal that will encompass all aspects of cell cycle control in eukaryotes. The journal aims to publish articles on all aspects of cell-cycle research and to bridge the gap between models of cell cycle regulation, development, and cancer biology. This forum will be driven by specialised and timely research articles, reviews and commentaries focused on this fast moving field, providing an invaluable tool for cell-cycle biologists.
Epigenetics & Chromatin welcomes all high-quality articles that provide novel insights into epigenetic inheritance and chromatin-based interactions. Topics include, but are not limited to, gene silencing and imprinting, cellular reprogramming, nucleosome modification assembly and remodeling, DNA methylation, chromatin structure and dynamics, chromosomal maintenance elements, dosage compensation, interchromosomal interactions and prion inheritance.
Search for more STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
